Kim Smith-Whitley
Chief Tech/Sci/R&D Officer at GLOBAL BLOOD THERAPEUTICS, INC.
Kim Smith-Whitley active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-04-30 | - |
| Sickle Cell Disease Association of America, Inc. | Director/Board Member | - | - |
| Director of Finance/CFO | - | - |
Career history of Kim Smith-Whitley
Training of Kim Smith-Whitley
| George Washington University | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
| Sickle Cell Disease Association of America, Inc. | |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Kim Smith-Whitley
- Experience
